Benchling

“We're realizing that if our goal is to accelerate IND timelines, we really need to have consistent, clean data and communication across different teams,” says Manasi Nawathe. Three industry experts share insights on accelerating process development with technology: 1?? As the science and industry evolves, recognize when your current technology needs to evolve too 2?? Model-based architecture can help unify data across an organization 3?? AI can accelerate process dev, but it’ll require common data architecture and accessibility Read more: https://lnkd.in/gt_xXxd9 ???? Will you be at #Biologics World Nordics in Stockholm this week? Visit us at booth #15 to talk about Benchling — the only cloud-native solution for end-to-end, high throughput process development! #BWN2025

? Sometimes it’s the simple pleasures. ? Turn your table columns into single input fields — so you can automatically apply the same value across all your rows. #FeatureFriday

?? #TeamScience at the Museum of the African Diaspora! Earlier this month, Benchlings spent an afternoon at the MoAD, to celebrate and learn about Black cultures. As #BlackHistoryMonth comes to a close, we’d like to recognize our employee resource group for #BIPOC Benchlings and allies. From round table discussions, to donation campaigns for Black-focused charities, and of course, snacks from Black-owned businesses, our BIPOC group has created space for reflecting on the history, contributions, and resilience of Black communities — not just this month, but year-round. Special appreciation goes to Travis B. Mitchell, who’s led our BIPOC group for several years — thank you for making our community a more vibrant and inclusive place. We also welcome the group’s new co-leads Diamond Miller and Kasjah Scarlett! ?? In the spirit of lifting up Black voices and experiences, here’s what we’re reading this month. A case study on biculturalism and challenges faced by Black students in #STEM ???? https://lnkd.in/ePNjb-tq

How are the most cutting-edge #immunology companies using Benchling to achieve end-to-end data automation? See how Vir Biotechnology, Inc. is powering the immune system to treat serious infectious diseases and cancer. With Benchling, they’re collaborating and developing more efficiently than before, with: ? End-to-end data automation, from data capture through analysis ? 58% time savings on data entry, QC, and search ? $10M saved annually ?? Get the details: https://lnkd.in/djvYvBrR #BuiltOnBenchling

What if you could develop a new AAVs for gene therapies in just four hours — compared to the four weeks it takes to develop a cell in the traditional way? Fuse Vectors is developing a cell-free viral vector technology to do just that. Now with their $5.2M pre-seed fundraising round, the Danish company will trial their technology with pharma and academic partners over the coming months. Congrats to the team! ?? https://lnkd.in/ehQr4viV ?? See how Fuse is innovating faster with a unified data capture and management system: https://lnkd.in/eE_CXXdQ #BuiltOnBenchling

“You can’t fake development,” says Benchling CRO Parm Uppal. “Real growth happens when you prioritize people, invest in their development, and create an environment and culture where leaders emerge through an unwavering focus on development.” It’s been less than a year since Parm joined Benchling, and already, this philosophy is shaping the culture of our Sales team. In the last performance cycle alone, the team celebrated 18 internal promotions. With over 20 years’ experience as a GTM leader, Parm has seen it time and again: “Investing in people is the surest path to drive revenue growth.” Read about his perspective: https://lnkd.in/e8JGJKBi Want to join #TeamScience? We’re hiring for Sales roles across the U.S. and Europe: https://lnkd.in/eTpEWTAR

“I think there's huge opportunity, not just to 10x the number of medicines that we get to market,” says Sajith Wickramasekara on BBC News, "but to make every step of getting them through the process of drug research and development way faster, way more automated, and take fewer people.” "The industry should be aiming for 500, not 50, drugs per year, and to do it faster," says Saji. “That's where we come in at Benchling. We build technology that makes R&D faster, and I think there's never been a greater need.” He spoke with BBC News about #biotech’s productivity challenges, the industry’s changing global landscape, and how technology like #AI will fuel greater innovation. As BBC News presenter Ben Thompson put it: “There is a possibility here, of course, you could facilitate something really game-changing in curing a disease or solving a global problem. That's really exciting, isn't it?” Learn about Benchling: https://lnkd.in/dpMZYhjm

#TeamScience gives back! Our team recently volunteered at GLIDEsf, serving meals to those in need, and with The Hand Project, assembling prosthetic hands for donation in developing countries. Our focus will always be on serving our customers in #biotech, but it’s also important to remember the larger community that we’re a part of. Thank you Benchlings for donating to or volunteering at over 180 nonprofits last year! #BenchlingForGood

? Your notebook just got prettier. ? Annotate your images with text, arrows, and circles — using a simple drag-and-drop tool. Ready, get set, annotate! ?? #FeatureFriday

“A lot of the current problems with viral vectors used in gene therapy can be traced back to manufacturing problems,” says Stefan Kol. “It’s very expensive, which makes gene therapy some of the most expensive drugs out there.” That’s why Fuse Vectors is on a mission to enable access to gene therapies through disruption of manufacturing. See how they’re developing and collaborating faster with a data capture and management system that ensures end-to-end traceability. https://lnkd.in/eE_CXXdQ #BuiltOnBenchling